Acurx Pharmaceuticals Inc.
NY
- UEI
- DTLFCU5DAXV4
- CAGE
- 87AL5
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 259 Liberty Ave, Staten Island, NY 10305, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
SBA capabilities narrative
Early stage biopharmaceutical company focused on development of antibiotics that address difficult to treat bacterial infections. Acurx's approach to counter the emergence of antibiotic-resistant bacterial infections is to develop new antibiotics that effectively block an entirely new molecular target, DNA polymerase IIIC enzyme.
Quick answers
Is Acurx Pharmaceuticals Inc. registered in SAM.gov?
Yes. Acurx Pharmaceuticals Inc.'s SAM.gov registration is active through March 11, 2027.
On GovTribe
See Acurx Pharmaceuticals Inc.'s full federal record
- Similar vendors